emerg
new
viru
heterogen
grow
alarm
rate
sudden
outburst
nipah
viru
niv
rais
seriou
question
instant
manag
use
convent
medic
diagnost
measur
coher
strategi
versatil
comprehens
perspect
confront
rise
distress
could
perhap
effectu
implement
nanotechnolog
concurr
resourc
precis
execut
nanobas
medic
ultim
need
concret
understand
niv
pathogenesi
moreov
amplifi
effect
nanobas
approach
conquest
niv
list
develop
nanosystem
antivir
activ
also
prerequisit
therefor
present
review
provid
meticul
cogniz
cellular
molecular
pathogenesi
niv
convent
well
sever
nanobas
diagnosi
experiment
virus
discuss
lastli
potenti
efficaci
differ
form
nanobas
system
conveni
mean
shield
mankind
niv
also
introduc
view
adapt
nanotechnolog
achiev
past
decad
certain
nanosci
consist
intensifi
horizon
across
globe
present
centuri
come
despit
expend
plastic
nanotechnolog
applic
wide
gap
intrigu
experiment
biomed
applic
substanti
commerci
moreov
applic
biomed
scienc
still
lurk
priorit
order
bridg
gap
addit
efficaci
convent
therapi
gradual
fade
away
specif
case
viral
infect
due
develop
resist
could
certainli
due
acceler
adapt
peripher
protein
sequenc
result
newfangl
viral
strain
van
woensel
et
al
instanc
state
virus
ubiquit
caus
lower
respiratori
tract
diseas
babi
youngster
later
variat
coronaviru
associ
sever
acut
respiratori
syndrom
human
metapneumoviru
late
recogn
new
respiratori
pathogen
entir
age
rang
emerg
present
nipah
viru
niv
anoth
respiratori
tract
infect
viru
estim
case
fatal
rate
rang
caus
seriou
issu
world
indic
factsheet
report
lower
respiratori
infect
rank
lead
caus
mortal
low
incom
countri
high
incom
countri
respect
lead
caus
mortal
worldwid
viru
high
rate
morbid
mortal
extent
strangl
virologist
sinc
past
year
exig
novel
therapeut
moreov
convent
unidirect
serolog
diagnosi
therapeut
orchestr
numer
shortcom
cost
deficit
sophist
prepar
procedur
effici
postexposur
prophylaxi
reduc
amount
product
consist
human
popul
livestock
vaccin
major
therapeut
develop
basic
includ
monoclon
antibodi
target
viral
surfac
protein
f
g
protein
number
broad
spectrum
antivir
agent
nucleosid
analogu
name
rebavirin
remdesivir
balapiravir
recent
drug
favipiravir
inhibitor
viral
rnadepend
rna
polymeras
shown
certain
degre
effici
viru
lack
target
specif
action
probabl
host
cell
toxic
major
limit
synthet
drug
take
consider
sever
infect
imper
necess
novel
multidirect
target
specif
nontox
natur
tunabl
nanotechnolog
base
approach
seem
promis
altern
technolog
harbor
certain
fascin
properti
superparamagnet
high
surfac
plasmon
reson
luminesc
photon
upconvers
bioavail
biocompat
immunocompat
toler
biodegrad
capac
channel
transluc
breachabl
bloodbrain
barrier
bbb
bloodair
barrier
bab
tunabl
target
control
discharg
chief
exclus
point
qualifi
novel
candid
util
biomed
therapi
antivir
focal
point
present
review
paper
includ
cellular
molecular
pathogenesi
niv
infect
heterogen
form
nanobas
approach
use
mean
therapi
diagnost
virus
final
provis
futur
possibl
nanotechnolog
concern
niv
detect
inhibit
human
sever
acut
respiratori
sick
enceph
provok
batborn
zoonot
paramyxovir
pathogen
niv
negativesens
singlestrand
rna
viru
belong
famili
paramyxovirida
genu
henipaviru
close
relat
hendra
virus
like
hendra
viru
niv
may
also
caus
fatal
pneumonia
acut
respiratorydistresslik
syndrom
hypothes
respiratori
diseas
transmiss
pathogenesi
link
infect
epitheli
cell
niv
lower
respiratori
tract
primari
phase
recent
escaffr
et
al
describ
two
type
infect
associ
niv
name
nivm
nivb
human
respiratori
tract
base
differenti
epitheli
model
trachea
small
airway
due
close
anatom
resembl
epitheli
cell
human
lower
respiratori
tract
accord
epidemiolog
report
nivm
nivb
infect
vari
greatli
multipl
aspect
instanc
percentag
respiratori
diseas
case
fatal
rate
nivb
infect
much
higher
nivm
infect
wherea
nivm
infect
studi
show
human
hamster
develop
similar
patholog
chang
presenc
vascul
necrosi
inflamm
certain
neuron
chang
antigen
posit
neuron
microvascular
vascul
necrosi
hamster
case
human
progress
enceph
extracellular
pleomorph
bilay
envelop
spike
two
glycoprotein
name
trimer
fusion
protein
f
tetramer
attach
protein
g
exterior
surfac
matrix
protein
interior
surfac
encapsul
niv
virion
negativesens
singlestrand
rna
along
three
critic
vital
protein
name
nucleocapsid
protein
n
phosphoprotein
p
larg
polymeras
protein
l
contain
within
virion
made
linear
ribonucleoprotein
rnp
bind
viral
g
conserv
receptor
mark
begin
host
cell
viral
membran
fusion
mediat
prior
complex
format
viral
g
f
protein
evolutionari
point
view
could
assum
initi
epidem
period
niv
develop
specif
mechan
evad
innat
immun
action
pterou
bat
evolutionari
conserv
particular
immun
mechan
within
mammal
made
niv
broad
spectrum
viru
viru
block
elicit
innat
adapt
immun
respons
inhibit
synthesi
cytokin
interferon
type
ifn
ifn
case
viral
infect
activ
pathway
within
viral
infect
cell
degrad
viral
mrna
inhibit
viral
protein
synthesi
henc
hinder
rate
viral
replic
insid
infect
cell
subsequ
lower
viral
load
song
et
al
describ
ifn
act
autocrin
paracrin
signal
molecul
ifn
ifn
produc
therefor
could
said
inhibit
ifn
synthesi
may
sever
affect
autocrin
paracrin
activ
may
lead
impair
immun
respons
barth
et
al
cellular
molecular
chang
post
niv
infect
start
right
niv
attach
invas
pathogenesi
lead
multipl
organ
failur
explain
figur
understand
chang
significantli
improv
present
knowledg
essenti
develop
evalu
therapeut
niv
niv
infect
primari
stage
restrict
within
epitheli
cell
host
upper
lower
respiratori
tract
nivf
g
necessari
fusion
bipolar
epitheli
cell
epic
side
initi
infect
period
g
protein
induc
viruscel
fusion
begin
interact
tetramer
gprotein
head
region
ephrin
epitheli
cell
simultan
cterminu
region
g
interact
nivf
protein
whose
two
hydrophob
ntermin
alpha
helic
heptad
repeat
domain
form
sixhel
bundl
structur
transvers
cell
membran
host
initi
ph
independ
class
type
membran
fusion
figur
viral
entranc
apic
region
replic
within
cell
sort
protein
f
g
infect
cell
surfac
destin
infect
could
also
regard
marker
unlik
g
precursor
form
f
protein
f
get
lodg
within
membran
activ
endocytosi
follow
cathepsin
l
mediat
endosom
degrad
form
matur
f
et
al
local
infect
start
later
spread
viru
occur
basolater
express
protein
g
f
mediat
cellcel
merg
give
rise
consequenti
configur
syncytia
patholog
hallmark
niv
infect
epitheli
cell
seen
h
post
infect
pi
earliest
time
need
protein
detect
vivo
studi
cellcel
fusion
epitheli
cell
stromal
cell
heterolog
fusion
two
epitheli
cell
homolog
fusion
figur
disrupt
monolay
epitheli
cell
newli
form
viru
bud
apic
side
multinucl
epitheli
cell
vectori
releas
viru
confirm
preferenti
local
viral
f
g
necessari
bud
protein
apic
side
total
g
f
respect
seen
h
pi
releas
viru
either
infect
immun
cell
secondari
lymphoid
organ
mucos
associ
lymphoid
tissu
malt
gut
associ
lymphoid
tissu
galt
present
layer
mucos
epithelia
cell
might
also
contribut
toward
impair
antivir
activ
inhibit
synthesi
ifn
reduc
express
cytokin
involv
inflammatori
process
like
ifn
induc
antivir
gene
mxa
repress
viral
antigen
present
classi
mhc
molecul
might
anoth
output
figur
unconstrain
viru
could
infiltr
blood
stream
attach
leukocyt
macrophag
dendrit
cell
cell
nk
cell
caus
system
infect
multipl
organ
failur
detail
brain
lung
liver
heart
kidney
spleen
figur
histopatholog
lesion
necrosi
vascul
noncn
organ
case
cn
organ
perivascular
cuf
parenchym
inflamm
neurophangia
common
clinic
sign
exclus
niv
infect
may
also
detect
acut
viral
enceph
figur
mortal
rate
outrag
rang
host
atroci
human
pathogen
also
infect
neuron
apart
endotheli
cell
gener
paramyxovirus
evad
host
immun
system
either
suppress
detect
lower
express
pattern
recognit
receptor
prr
imped
secret
antivir
signal
molecul
case
niv
viral
p
gene
encod
posttranscript
modifi
phosphoprotein
antagon
secret
ifn
elicit
antivir
activ
cytoplasm
nucleolu
variou
protein
encod
p
gene
p
v
w
c
amino
acid
length
similar
n
termin
end
v
w
mrna
frame
shift
mutat
p
mrna
particular
conserv
site
insert
one
two
g
nucleotid
respect
wherea
c
mrna
nest
within
p
v
w
mrna
degre
immun
respons
inhibit
protein
p
v
w
vari
p
less
v
w
highest
inhibitori
activ
elev
inhibit
w
protein
might
nuclear
local
abil
allow
suppress
express
ifn
antivir
gene
gene
express
level
confirm
lower
probabl
elicit
antivir
activ
happen
case
cytoplasm
inhibit
v
protein
cytoplasm
inhibitori
activ
v
protein
achiev
bind
dsrna
respond
rlr
receptor
henc
regul
activ
activ
ifn
gene
transcript
factor
figur
suppress
ifn
gene
express
overcom
anoth
mediat
altern
pathway
produc
amount
adaptor
protein
activ
figur
attenu
ifn
respond
antivir
activ
infect
cell
discuss
consid
jackstat
signal
pathway
necessari
transcript
level
activ
antivir
gene
respond
ifn
interact
phosphoryl
form
hetero
homodim
respect
figur
dimmer
precursor
molecul
ifn
gene
transcript
factor
henc
inhibit
interact
result
absenc
antivir
activ
protein
p
v
w
interact
amino
termin
domain
protein
v
interact
reloc
nonphosphoryl
typic
cytoplasm
locat
protein
w
also
make
unavail
stat
dimer
format
henc
inhibit
ifn
gene
transcript
factor
format
figur
viral
c
protein
predominantli
local
cytoplasm
partli
nucleu
respons
envelop
viral
bud
releas
recruit
host
escrt
pathway
c
termin
domain
nivc
possess
homolog
sequenc
host
protein
could
interact
directli
tsg
adaptor
molecul
escrt
escrt
ii
howev
reciproc
action
among
escrt
iniv
c
escrt
ii
fulli
understood
specul
viral
c
protein
interact
protein
present
inner
leaflet
plasma
membran
therebi
direct
vectori
releas
viru
particl
figur
therapeut
niv
guillaum
et
al
develop
potent
vaccinia
viru
vv
mediat
vvnivf
vvnivg
recombin
vaccin
hamster
model
found
immun
organ
show
complet
immun
niv
induc
fatal
enceph
produc
neutral
antibodi
wherea
occur
within
day
intraperiton
inocul
niv
isol
low
neutral
abil
produc
antibodi
confirm
increas
level
serum
antibodi
give
idea
studi
effect
passiv
immun
niv
intraperiton
inject
polyclon
well
monoclon
mab
antif
antig
separ
show
antif
antig
mab
effici
neutral
niv
viral
infect
compar
polyclon
ab
antif
mab
high
degre
antivir
activ
antig
mab
recent
hit
broadspectrum
small
molecul
antivir
purin
analogu
previous
mention
favipiravir
inhibit
niv
hev
replic
vitro
minim
cytotox
effect
highest
concentr
test
cc
valu
observ
hamster
model
provid
way
fight
cytopath
effect
deadli
niv
hev
like
paramyxovirus
late
one
day
due
consist
chang
genom
pathogen
would
get
resist
convent
drug
unidirect
specif
target
limit
could
amelior
find
novel
therapi
multipl
pathway
biomark
target
orient
action
exampl
niv
deplet
nivc
recruit
escrt
pathway
mechan
deposit
viral
protein
n
f
g
l
result
cytoplasm
bud
impair
releas
viru
infect
cell
versatil
mode
viral
inhibit
primarili
depend
type
form
np
use
therefor
understand
antivir
activ
np
gener
overview
differ
type
form
np
nanobas
system
necess
nanobas
antivir
agent
extend
simpl
inorgan
np
complex
organ
hybrid
nanosystem
metal
np
mnp
nc
form
nanospher
nanocapsul
nanocag
could
categor
inorgan
np
inp
organ
np
onp
includ
nanocapsul
form
nc
primarili
differenti
base
chemic
composit
hybrid
nanosystem
standard
amalgam
inorganicorgan
inorganicinorgan
nanocomposit
organicorgan
nanoparticul
system
lipidpolym
hybrid
np
engin
base
specif
requir
use
target
site
properti
luminesc
tunabl
size
shape
composit
larg
surfaceto
volum
ratio
invigor
import
inp
biomed
field
multifari
applic
among
applic
abil
inp
expos
multipl
surfac
bind
site
well
control
vivo
behavior
properti
wide
explor
phenomenon
multipl
interact
specif
site
target
molecul
contribut
toward
util
np
activ
target
imag
diagnost
hyperthermia
therapi
medic
common
inp
mnp
silver
ag
gold
au
iron
oxid
feo
nc
silica
titanium
carbon
etc
silver
nanoparticl
agnp
keenli
research
nanobas
approach
treat
viral
infect
detect
numer
evalu
np
develop
novel
strategi
either
annihil
amelior
sever
infect
alreadi
carri
date
effici
agnp
antivir
check
human
immunodefici
viru
hiv
herp
simplex
viru
hsv
felin
caliciviru
polioviru
pest
de
petit
rumin
viru
pprv
murin
avian
normal
interact
host
receptor
associ
coreceptor
result
conform
chang
viru
expos
concordantli
interact
releas
viral
core
cytoplasm
find
suggest
agnp
imped
virion
bind
merg
pathogenesi
interact
viral
cellfre
cellassoci
viru
case
viral
inhibit
portray
interact
sulfhydryl
group
present
membran
glycoprotein
prevent
viral
intern
pest
de
petit
rumin
viru
np
act
interact
virion
surfac
core
protein
impair
viral
replic
entri
likewis
dsrna
virus
agnp
interact
viral
genom
np
found
inhibit
viral
replic
antivir
efficaci
agnp
mode
viral
entri
attach
inhibit
viral
replic
inhibit
also
evalu
virus
shown
tabl
unlik
agnp
though
aunp
could
also
synthes
green
synthesi
method
direct
use
antivir
agent
scant
except
find
aunp
stabil
certain
biocompat
polym
could
act
effect
antivir
agent
dengu
viru
bovin
viral
diarrhea
viru
footandmouth
diseas
viru
fmdb
vijayakumar
ganesan
et
al
specul
mode
antivir
activ
polyethylen
glycol
encapsul
aunp
might
block
attach
result
inhibit
viral
entri
hafashjani
et
al
find
later
suggest
aunp
arrest
fmdv
replic
postentri
stage
associ
specif
transcript
within
host
cell
exact
virucid
mechan
unclear
current
use
aunp
combin
nanobas
formul
appli
phototherm
nanotherapi
biosens
bioimag
catalyt
activ
uniqu
properti
aunp
contribut
applic
differ
bulk
form
surfac
enhanc
raman
scatter
ser
iron
oxid
superparamagnet
iron
oxid
form
either
magnetit
fe
maghemit
fe
np
imper
compon
present
day
magneto
respons
nanoparticul
system
iron
base
nanoparticul
system
creat
tremend
impact
biomed
clinic
diagnost
includ
magnet
reson
imag
magnet
particl
imag
magnet
fluid
hyperthermia
magnet
label
cell
separ
therefor
direct
applic
mnp
therapeut
limit
present
direct
use
mnp
antivir
agent
evalu
bacteriophag
highli
infecti
virus
like
zika
viru
hcv
tabl
mani
find
exploit
mnp
applic
hybrid
form
much
appreci
describ
later
hybrid
nanoparticl
tabl
due
bright
high
refract
index
titanium
dioxid
tio
white
pigment
molecul
wide
use
number
purpos
variou
sector
scienc
industri
nanoform
tio
np
abundantli
produc
use
specif
high
solubl
photocatalyt
anticorros
properti
although
applic
biomed
sector
marvel
still
larg
gap
classic
current
research
everi
possibl
implement
could
bridg
gap
antivir
applic
tio
np
one
present
antivir
evalu
tinp
limit
influenza
viru
certain
bacteriophag
fr
mani
other
moreov
exist
toxic
evalu
np
though
complet
elimin
health
risk
therefor
biomed
applic
antivir
agent
question
consid
benefici
role
tinp
biomed
sector
antivir
activ
howev
need
perfectli
conceptu
anim
model
np
base
silica
due
uniqu
characterist
like
tunabl
diamet
pore
size
conveni
function
biocompat
etc
well
appreci
research
globe
apart
two
import
properti
display
manipul
applic
properti
includ
selfimmobil
ligand
onto
surfac
sinp
stimulirespons
gatekeep
practic
applic
lie
capabl
control
acceler
releas
drug
payload
simultan
exclud
prematur
releas
current
exploit
properti
photodynam
therapi
function
sinp
photosensit
one
fastest
emerg
research
differ
form
sinp
categor
porou
mesopor
nonpor
util
divers
biomed
applic
multipl
biomed
applic
sinp
present
review
focus
antivir
activ
research
antivir
therapeut
diagnost
exploit
silica
base
np
limit
current
antivir
efficaci
sinp
virus
like
human
papilloma
viru
porcin
circoviru
hepat
b
viru
hiv
recombin
virus
evalu
tabl
mode
antivir
activ
either
mediat
immun
host
viru
inhibit
viral
entri
viral
protein
base
fluoresc
detect
nucleic
acid
hybrid
two
major
method
viral
detect
despit
progress
made
therapeut
diagnost
viral
infect
achiev
question
grow
demand
novel
antivir
therapeut
diagnost
supplement
research
evalu
carbonbas
nanocarri
among
frequent
wide
evalu
nanoparticul
system
biomed
applic
carbonbas
materi
fulleren
carbon
nanotub
nanohoron
nanodot
graphem
nanodiamond
etc
also
possess
mention
inimit
properti
optic
electron
mechan
thermal
properti
gain
much
attent
past
decad
among
variou
beneficiari
role
biocompat
vivo
biodistribut
biodegrad
biocorona
format
etc
crucial
properti
constantli
impress
present
scientif
commun
till
today
although
carbonbas
nanomateri
support
spectacular
advantag
properti
still
util
evalu
field
virolog
limit
virus
tabl
antivir
virucid
activ
carbonbas
nanomateri
evalu
virus
ebola
viru
pseudotyp
viral
particl
bacteriophag
grass
carp
reoviru
gcrv
respiratori
syncyti
viru
rsv
variou
mode
viral
inhibit
carbonbas
nanomateri
use
carrier
repres
tabl
advanc
evalu
carbonbas
nanosystem
viral
infect
though
develop
immens
commerci
ratelimit
phase
resolv
respect
time
nanos
semiconductor
crystal
commonli
known
quantum
dot
qd
except
electron
optic
properti
highli
appreci
specif
intens
fluoresc
high
quantum
yield
sizetun
light
emiss
appreci
chemic
photost
revolution
concept
nanobas
sens
diagnost
gener
element
composit
qd
includ
cadmium
cd
lead
pb
mercuri
hg
zinc
zn
recent
develop
ternari
iiiivi
qd
contain
element
differ
form
repres
cupper
cu
silver
ag
iii
repres
gadolinium
ga
indium
vi
repres
sulfur
selenium
se
owe
extrem
small
size
rang
nm
qd
well
appreci
use
biomed
sector
could
conveni
cross
bbb
conjug
therapeut
molecul
mahajan
et
al
show
fluoresc
quantum
rod
qr
form
qd
conjug
transfer
target
molecul
haat
highli
activ
antiretrovir
therapi
drug
sequinavir
could
freeli
cross
vitro
model
bbb
also
show
nanoformul
show
promis
antivir
activ
viral
detect
qd
base
approach
exceedingli
escal
research
virolog
norouzi
et
al
develop
cadmiumtellurium
qd
associ
biotin
acceptor
nh
receptor
probe
target
dna
recognit
human
tlymphotrop
vitro
likewis
mani
evalu
qd
util
either
therapeut
vitro
diagnosi
viral
pathogen
size
therapeut
compound
larg
inp
might
prove
promis
carri
deliv
desir
compound
condit
organ
nanoparticl
onp
might
prove
benefici
order
effici
carri
deliv
drug
load
use
onp
inp
well
appreci
biomed
sector
specif
due
variou
safeti
issu
encapsul
drug
favor
avoid
offtarget
toxic
result
enhanc
augment
target
site
mode
deliveri
therapeut
could
modul
select
specif
design
featur
chemic
requir
synthesi
purpos
sinc
sustain
releas
kinet
directli
influenc
therapeut
compet
toxic
nanosystem
multipl
form
onp
exploit
field
nanomedicin
certain
specif
onp
present
evalu
antivir
activ
includ
polymer
np
lipid
base
np
dendrim
neosom
nanomicel
tabl
exploit
polymer
np
progress
effectu
antivir
treatment
go
decad
variou
form
polym
synthet
natur
immens
contribut
toward
meticul
understand
definit
properti
biodistribut
bioavail
biocompat
immunocompat
etc
biomed
sector
use
either
develop
improv
antivir
investig
pathogen
virus
like
influenza
hiv
rabi
viru
tabl
effici
selfassembl
properti
nanos
shape
abil
function
base
requir
either
carri
desir
therapeut
agent
core
conjug
target
molecul
surfac
simpli
magnific
recent
joshi
et
al
demonstr
amin
function
polymer
gelatin
np
load
zidovudin
hiv
simultan
also
conduct
hemolysi
aggreg
studi
gain
deeper
understand
compat
properti
np
research
summar
drug
conjug
np
show
promis
biocompat
antivir
activ
deng
et
al
hand
took
differ
approach
develop
univers
influenza
vaccin
doublelay
protein
np
compos
tetramar
matrix
protein
core
headless
hemagglutinin
ha
coat
surfac
protein
vaccin
could
induc
substanti
prolong
immun
complet
protect
balbc
mice
veriti
influenza
viru
challeng
contemporari
improv
made
nanosci
certain
impecc
polymer
np
near
futur
soon
use
develop
novel
antivir
diverg
array
infecti
virus
like
niv
current
develop
solidlipid
np
nanostructur
lipid
nanocarri
demonstr
abil
except
effici
biocompat
vehicl
therapeut
field
advanc
medicin
among
multipl
possibl
applic
lipid
base
np
exploit
formul
novel
antivir
could
assum
primari
concern
ongo
research
anomal
bioabsorb
biocompat
properti
grant
nanosystem
uniqu
prospect
view
despit
past
limit
seem
difficult
therapeut
migrat
across
bbb
seem
promis
introduct
multifunct
lipid
base
nanocarri
rg
kerri
et
al
nanomedicin
nanotechnolog
biolog
medicin
similarli
gao
et
al
design
nanostructur
nanolipid
carrier
load
podophyllotoxin
pod
evalu
drug
releas
paramet
hemocompat
nontox
viral
inhibit
cell
line
challeng
human
papillomaviru
hpv
lipid
base
np
form
solidlipid
np
nanostructur
lipid
nanocarri
could
serv
except
addit
group
vehicl
need
effect
antivir
deliveri
current
investig
lipidbas
np
base
antivir
virus
hepat
c
viru
hiv
hpv
document
tabl
certainli
futur
marvel
nanosystem
could
get
even
better
hybrid
could
use
effici
therapi
niv
dendrim
organ
compound
wellorgan
hyperbranch
molecul
receiv
much
attent
late
owe
improv
monodispers
biocompat
biodegrad
field
nanomedicin
molecul
also
extraordinari
vehicl
gene
peptid
drug
natur
synthet
deliveri
target
site
within
biolog
system
wide
use
biomed
scienc
applic
util
evalu
antivir
limit
date
dendrim
antivir
activ
conjug
therapeut
agent
alreadi
document
virus
includ
influenza
viru
ebola
viru
zika
viru
hiv
tabl
antivir
effici
nanosystem
result
viral
entri
inhibit
activ
cell
antibodi
mediat
respons
case
rna
decoy
investig
regard
efficaci
dendrim
nanoperticul
system
design
antivir
therapi
introduc
pioneer
research
effici
niv
yet
evalu
nonion
surfactantbas
vesicl
short
niosom
structur
similar
liposom
slowli
becom
center
attract
current
investig
physic
chemic
properti
stabil
optic
activ
biocompat
biodegrad
nonimmunogen
conveni
function
greatli
influenc
scientif
commun
addit
effici
load
lipophil
hydrophil
drug
superior
bioavail
guard
releas
intend
site
grant
niosom
uniqu
prospect
field
nanomedicin
despit
immens
signific
use
niosom
biomed
sector
specif
formul
antivir
agent
limit
exampl
till
antivir
activ
hsv
document
tabl
javad
et
al
monavari
et
al
evalu
efficaci
acyclovir
load
nanoniosom
found
neosom
load
drug
show
promis
antivir
activ
improv
deliveri
releas
kinet
vivo
evalu
requir
display
antivir
efficaci
broad
rang
infecti
virus
niv
nanomicel
supramolecular
assembl
surfact
molecul
dissemin
colloid
liquid
give
rise
globular
micel
rang
nanos
effici
encapsul
biocompat
colloid
stabil
prolong
circul
time
etc
influenti
properti
polymer
micel
moreov
compound
possess
properti
huge
signific
nanomedicin
drug
deliveri
system
tabl
specif
formul
antivir
agent
polymer
nanomicel
appreci
exampl
naseri
et
al
formul
nanomycel
encapsul
bioactiv
phytocompound
curcumin
verifi
bioavail
antivir
activ
vitro
document
nanoformul
display
better
bioavail
satisfactori
antivir
activ
present
applic
marvel
compound
somewhat
stagnant
need
contribut
research
world
hybrid
np
far
advanc
form
np
could
thought
present
centuri
inp
ag
au
magnet
np
tio
sio
cnt
fulleren
graphen
oxid
onp
polymer
np
lipid
np
niosom
explor
antivir
activ
number
virus
np
hybrid
state
evalu
includ
hiv
influenza
viru
hepat
viru
human
adenoviru
etc
tabl
hybrid
np
virolog
may
categor
accord
util
either
diagnost
therapi
current
investig
effort
made
toward
diagnosi
detect
virus
document
mani
investig
differ
corner
globe
start
primari
applic
detect
et
al
earlier
report
accur
precis
enterovirus
label
procedur
describ
atom
level
report
watersolubl
thiolstabil
gold
cluster
chemic
call
au
paramercaptobenzo
acid
cluster
metal
core
could
coval
bind
cystein
molecul
nearer
surfac
viru
procedur
enterovirus
echoviru
coxsackieviru
virus
precis
detect
ahm
et
al
synthes
multifunct
nanohybrid
aunp
first
bond
cnt
surfac
specif
antibodi
antiinfluenza
viru
ha
antibodi
conjug
nanohybrid
display
oxid
catalysi
tmb
h
gave
rise
deep
blue
color
optic
densiti
depend
concentr
viru
late
oh
et
al
develop
ultrasensit
magnet
nanozymelink
immunosorb
assay
detect
viru
assay
two
major
compon
silicashel
magnet
nanobead
magnb
bind
preliminari
detect
viru
gold
nanozym
aunz
enzymelik
act
molecul
amplif
preliminari
detect
signal
togeth
combin
nanosystem
could
even
detect
viru
concentr
femtogram
per
millilit
number
exampl
hybrid
nanobas
system
show
promis
result
viral
detect
list
tabl
viral
inhibit
foremost
import
diagnosi
need
address
immedi
thereaft
requir
novel
antivir
combat
viral
infect
becom
primari
concern
develop
antivir
within
stipul
time
actual
race
time
case
formul
antivir
biocompat
nonimmunogen
nontox
critic
requir
hybrid
nanoparticul
system
appreci
option
promis
antivir
activ
system
portray
variou
scientif
investig
ryoo
et
al
report
ironoxid
npbase
deliveri
dnazym
therapeut
treat
hepat
c
infect
magnet
np
link
cellpenetr
peptid
cpp
function
dnazym
could
induc
knockdown
hvc
gene
nonstructur
protein
encod
viral
helicas
proteas
orlowski
et
al
develop
tannic
acid
function
agnp
specif
size
rang
could
reduc
infect
block
viral
attach
penetr
well
viral
spread
provid
prior
direct
attach
nanosystem
viru
basic
requir
chen
et
al
compar
antivir
activ
graphen
oxid
go
go
conjug
adnp
coronaviru
fcov
infecti
bursal
diseas
viru
ibdv
analys
show
go
nonconjug
conjug
form
differ
effect
two
differ
taken
virus
overal
conclud
go
conjug
form
goagnp
could
inhibit
viru
fcov
ibdv
effect
diagnosi
therapi
next
aris
huddl
drug
resist
soon
must
focus
act
accordingli
intent
li
et
al
much
evalu
strateg
understand
drawback
convent
nanobas
antivir
design
nanoparticul
system
decor
amantadin
surfac
selenium
np
senp
design
seam
nanosystem
could
revers
drug
resist
induc
viru
similarli
mani
investig
orchestr
experiment
effici
hybrid
nanoparticul
system
antivir
list
tabl
despit
heterogen
research
investig
exploit
multipl
way
mean
diagnos
inhibit
viru
nanobas
therapeut
agent
revers
drug
resist
still
hardli
sign
applic
concern
niv
elev
cost
case
toxic
convent
avail
specif
antivir
therapeut
creat
appar
requir
specif
rapid
viral
diagnosi
specif
viral
diagnosi
may
help
discontinu
broad
spectrum
antibiot
therapi
determin
prognosi
also
believ
rapid
test
result
greatli
influenc
case
manag
prior
therapi
diagnosi
therefor
may
consid
import
aspect
viral
infect
treatment
multipl
method
present
era
laboratori
base
diagnosi
viral
infect
includ
serolog
viral
cultur
antigen
nucleic
acid
detect
convent
techniqu
viral
detect
viral
cultur
may
consid
techniqu
viabl
isol
could
obtain
futur
character
addit
detect
divers
array
virus
seem
promis
approach
also
advantag
antigen
detect
nucleic
acid
detect
order
preserv
medic
relev
virus
mainten
heterogen
type
cultur
cell
requir
support
major
limit
techniqu
viral
recoveri
cell
cultur
becom
difficult
viral
growth
slow
antigen
detect
case
much
use
rapid
nonrequir
viral
viabil
render
immens
plastic
manag
shift
specimen
togeth
may
consid
major
advantag
techniqu
fluoresc
antibodi
fa
stain
immunoperoxidas
stain
enzym
immunoassay
eia
etc
crucial
techniqu
involv
method
virus
antigen
heterogen
lack
crossreact
antigen
tediou
detect
even
techniqu
drastic
transform
diagnosi
emerg
develop
analysi
base
pcr
transform
allow
detect
specif
viral
sequenc
uttermost
sensit
specif
viral
rna
could
easili
detect
amalgam
revers
transcriptas
convent
pcr
analysi
realtim
pcr
assay
run
highli
sophist
autom
instrument
exploit
optic
excit
system
dye
label
fluoresc
molecul
tremend
reduc
time
probabl
contamin
versatil
nucleic
acid
detect
grow
daybyday
futur
progress
scientif
innov
final
efficaci
serolog
tradit
method
viral
diagnosi
disregard
techniqu
exclus
promis
unambigu
antivir
immun
determin
specul
clinic
util
assess
acut
convalesc
antibodi
titer
could
one
limit
case
niv
detect
mention
detect
techniqu
may
fruit
upon
consid
present
encroach
field
nanosci
virolog
intermedi
research
initi
new
direct
rapid
diagnosi
infecti
virus
like
aucu
coreshel
np
develop
brogli
et
al
human
noroviruslik
particl
detect
inactiv
capsid
protein
degrad
damag
similarli
hybrid
nanosystem
could
also
design
bind
niv
virion
two
spike
glycoprotein
f
g
well
rna
capsid
protein
n
p
l
contain
within
virion
figur
colorimetr
viral
detect
assay
exploit
peroxidaselik
activ
aunpscnt
nanohybrid
could
also
develop
detect
niv
detect
like
ahm
et
al
synthes
examin
nanohybrid
detect
likewis
number
versatil
experiment
tabl
diagnos
veriti
viral
infect
summar
contempl
possibl
probabl
develop
novel
nanobas
diagnosi
techniqu
detect
niv
could
achiev
niv
detect
could
possibl
elimin
viru
nanobas
system
far
reach
present
investig
convent
mean
viral
inhibit
treatment
therapi
document
topic
therapeut
niv
nanobas
approach
like
use
acid
function
multiwal
carbon
nanotub
mwct
made
photoactiv
molecul
protoporphyrin
ix
inactiv
viru
demonstr
banerje
et
al
possibl
molecular
mechan
involv
rosbas
inactiv
oxid
viral
protein
neuraminidas
na
hemagglutinin
ha
might
taken
place
singl
strand
break
viral
genom
proteinrna
crosslink
might
also
possibl
similar
nanobas
approach
includ
ph
phototherm
medium
accompani
rosbas
inactiv
niv
could
also
evalu
vitro
inhibit
viral
bind
host
cell
surfac
receptor
could
also
achiev
prevent
viral
bind
attach
studi
vijayakumar
ganesan
demonstr
mode
inhibit
viru
entri
use
aunp
vitro
similarli
np
capac
interact
niv
surfac
glycoprotein
like
g
f
could
prove
promis
candid
viral
entri
inhibitor
inhibit
viru
mediat
accumul
ro
activ
akt
phosphoryl
could
also
strategi
inhibit
entri
infecti
virus
li
et
al
demonstr
strategi
viral
inhibit
use
oseltamivir
otv
decor
senp
se
otv
strategi
could
effect
evalu
vitro
case
niv
inhibit
likewis
modul
viral
transcript
use
mwctsribavirin
zhu
et
al
target
bind
conserv
region
viral
genom
use
tio
np
polylysin
pl
contain
oligonucleotid
nanocomposit
levina
et
al
silenc
viral
replic
help
solid
lipid
np
torrecilla
et
al
etc
point
direct
tabl
though
effici
np
antivir
agent
niv
yet
evalu
still
could
roughli
specul
investig
direct
represent
possibl
np
hold
enorm
potenti
antivir
agent
niv
describ
figur
nanotechnolog
hold
tremend
opportun
viral
diseas
diagnosi
therapeut
evidenc
np
could
use
measur
revert
antivir
resist
slowli
develop
problem
convent
therapeut
avail
though
possibl
nanobas
approach
next
conveni
strategi
deal
niv
still
develop
np
difficult
niv
pathogenesi
properli
understood
therefor
present
review
provid
brief
knowledg
niv
pathogenesi
cellular
molecular
level
would
easi
strateg
novel
antivir
target
use
np
brief
introduct
variou
np
inorgan
organ
hybrid
form
would
help
determin
suitabl
evalu
diagnost
therapeut
final
overview
major
antivir
approach
alreadi
studi
repres
tabular
format
could
help
strateg
possibl
novel
antivir
approach
